CD4+CD28+KIR+CD11ahi T cells correlate with disease activity and are characterized by a pro-inflammatory epigenetic and transcriptional profile in lupus patients

J Autoimmun. 2018 Jan:86:19-28. doi: 10.1016/j.jaut.2017.09.011. Epub 2017 Oct 20.

Abstract

Objective: The goal of this study was to comprehensively characterize CD4+CD28+ T cells overexpressing CD11a and KIR genes, and examine the relationship between this T cell subset, genetic risk, and disease activity in lupus.

Methods: The size of the CD4+CD28+KIR+CD11ahi T cell subset was determined by flow cytometry, and total genetic risk for lupus was calculated in 105 female patients using 43 confirmed genetic susceptibility loci. Primary CD4+CD28+KIR+CD11ahi T cells were isolated from lupus patients or were induced from healthy individuals using 5-azacytidine. Genome-wide DNA methylation was analyzed using an array-based approach, and the transcriptome was assessed by RNA sequencing. Transcripts in the CDR3 region were used to assess the TCR repertoire. Chromatin accessibility was determined using ATAC-seq.

Results: A total of 31,019 differentially methylated sites were identified in induced KIR+CD11ahi T cells with >99% being hypomethylated. RNA sequencing revealed a clear pro-inflammatory transcriptional profile. TCR repertoire analysis suggests less clonotype diversity in KIR+CD11ahi compared to autologous KIR-CD11alow T cells. Similarly, primary KIR+CD11ahi T cells isolated from lupus patients were hypomethylated and characterized by a pro-inflammatory chromatin structure. We show that the genetic risk for lupus was significantly higher in African-American compared to European-American lupus patients. The demethylated CD4+CD28+KIR+CD11ahi T cell subset size was a better predictor of disease activity in young (age ≤ 40) European-American patients independent of genetic risk.

Conclusion: CD4+CD28+KIR+CD11ahi T cells are demethylated and characterized by pro-inflammatory epigenetic and transcriptional profiles in lupus. Eliminating these cells or blocking their pro-inflammatory characteristics might present a novel therapeutic approach for lupus.

Keywords: Chromatin accessibility; DNA methylation; Genetic risk; Lupus; T cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Black or African American*
  • CD11a Antigen / metabolism
  • CD28 Antigens / metabolism
  • CD4 Antigens / metabolism
  • Cells, Cultured
  • DNA Methylation
  • Disease Progression
  • Epigenesis, Genetic
  • Female
  • Genetic Profile
  • Humans
  • Immunophenotyping
  • Inflammation / immunology*
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / epidemiology
  • Lupus Erythematosus, Systemic / immunology*
  • Receptors, KIR / metabolism
  • Risk
  • Sequence Analysis, RNA
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocytes / immunology*
  • United States / epidemiology

Substances

  • CD11a Antigen
  • CD28 Antigens
  • CD4 Antigens
  • Receptors, KIR